Acorda Therapeutics Inc
NASDAQ:ACOR
Income Statement
Earnings Waterfall
Acorda Therapeutics Inc
Revenue
|
117.6m
USD
|
Cost of Revenue
|
-15.3m
USD
|
Gross Profit
|
102.4m
USD
|
Operating Expenses
|
-116m
USD
|
Operating Income
|
-13.6m
USD
|
Other Expenses
|
-239.2m
USD
|
Net Income
|
-252.9m
USD
|
Income Statement
Acorda Therapeutics Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
337
N/A
|
345
+3%
|
355
+3%
|
376
+6%
|
402
+7%
|
421
+5%
|
438
+4%
|
480
+10%
|
493
+3%
|
509
+3%
|
523
+3%
|
510
-2%
|
520
+2%
|
523
+1%
|
535
+2%
|
541
+1%
|
588
+9%
|
575
-2%
|
589
+2%
|
591
+0%
|
471
-20%
|
409
-13%
|
306
-25%
|
211
-31%
|
192
-9%
|
176
-8%
|
160
-9%
|
165
+3%
|
153
-7%
|
154
+1%
|
152
-1%
|
130
-14%
|
129
-1%
|
123
-5%
|
122
-1%
|
124
+2%
|
119
-4%
|
118
0%
|
117
-1%
|
111
-5%
|
118
+6%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(67)
|
(69)
|
(71)
|
(74)
|
(81)
|
(84)
|
(87)
|
(92)
|
(93)
|
(98)
|
(101)
|
(104)
|
(108)
|
(110)
|
(113)
|
(116)
|
(136)
|
(132)
|
(133)
|
(128)
|
(99)
|
(87)
|
(65)
|
(48)
|
(35)
|
(30)
|
(27)
|
(31)
|
(34)
|
(42)
|
(46)
|
(47)
|
(41)
|
(35)
|
(32)
|
(30)
|
(30)
|
(28)
|
(22)
|
(14)
|
(15)
|
|
Gross Profit |
270
N/A
|
276
+2%
|
285
+3%
|
302
+6%
|
321
+6%
|
337
+5%
|
350
+4%
|
388
+11%
|
400
+3%
|
411
+3%
|
421
+2%
|
406
-4%
|
412
+1%
|
413
+0%
|
422
+2%
|
425
+1%
|
453
+7%
|
443
-2%
|
456
+3%
|
462
+1%
|
372
-20%
|
323
-13%
|
241
-25%
|
163
-32%
|
158
-4%
|
147
-7%
|
133
-9%
|
134
+1%
|
120
-11%
|
112
-6%
|
106
-6%
|
83
-21%
|
88
+7%
|
88
0%
|
90
+2%
|
94
+5%
|
88
-6%
|
91
+3%
|
95
+5%
|
97
+2%
|
102
+6%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(239)
|
(240)
|
(246)
|
(254)
|
(278)
|
(306)
|
(324)
|
(357)
|
(366)
|
(393)
|
(423)
|
(438)
|
(448)
|
(447)
|
(439)
|
(399)
|
(389)
|
(660)
|
(617)
|
(335)
|
(334)
|
(328)
|
(329)
|
(261)
|
(192)
|
(139)
|
(338)
|
(115)
|
(136)
|
(153)
|
(153)
|
(166)
|
(161)
|
(151)
|
(151)
|
(140)
|
(123)
|
(94)
|
(88)
|
(87)
|
(116)
|
|
Selling, General & Administrative |
(186)
|
(184)
|
(187)
|
(192)
|
(202)
|
(204)
|
(206)
|
(209)
|
(206)
|
(216)
|
(226)
|
(229)
|
(235)
|
(228)
|
(215)
|
(201)
|
(182)
|
(177)
|
(172)
|
(175)
|
(172)
|
(177)
|
(183)
|
(188)
|
(193)
|
(181)
|
(170)
|
(161)
|
(153)
|
(144)
|
(138)
|
(125)
|
(119)
|
(114)
|
(111)
|
(107)
|
(106)
|
(102)
|
(94)
|
(94)
|
(90)
|
|
Research & Development |
(42)
|
(31)
|
(31)
|
(18)
|
(6)
|
(7)
|
(7)
|
(8)
|
(9)
|
(9)
|
(9)
|
(10)
|
(11)
|
(11)
|
(12)
|
(11)
|
(10)
|
(9)
|
(7)
|
(6)
|
(6)
|
(5)
|
(4)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
(10)
|
(18)
|
(26)
|
(31)
|
(31)
|
(31)
|
(31)
|
(31)
|
(31)
|
(31)
|
(31)
|
(31)
|
(31)
|
(31)
|
(31)
|
(31)
|
(31)
|
(31)
|
(31)
|
|
Other Operating Expenses |
(12)
|
(25)
|
(28)
|
(44)
|
(70)
|
(95)
|
(110)
|
(140)
|
(152)
|
(168)
|
(188)
|
(199)
|
(201)
|
(208)
|
(212)
|
(187)
|
(197)
|
(474)
|
(438)
|
(155)
|
(156)
|
(144)
|
(132)
|
(52)
|
30
|
75
|
(136)
|
79
|
50
|
23
|
17
|
(10)
|
(11)
|
(6)
|
(9)
|
(2)
|
14
|
39
|
37
|
38
|
4
|
|
Operating Income |
30
N/A
|
36
+19%
|
39
+6%
|
48
+24%
|
43
-9%
|
32
-27%
|
26
-17%
|
31
+19%
|
34
+9%
|
18
-47%
|
(2)
N/A
|
(33)
-1 950%
|
(36)
-10%
|
(34)
+5%
|
(17)
+49%
|
25
N/A
|
64
+153%
|
(217)
N/A
|
(161)
+26%
|
127
N/A
|
39
-70%
|
(5)
N/A
|
(88)
-1 526%
|
(98)
-12%
|
(34)
+65%
|
7
N/A
|
(206)
N/A
|
19
N/A
|
(16)
N/A
|
(41)
-153%
|
(47)
-15%
|
(84)
-78%
|
(73)
+13%
|
(63)
+14%
|
(61)
+3%
|
(46)
+26%
|
(35)
+23%
|
(3)
+91%
|
7
N/A
|
10
+34%
|
(14)
N/A
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(2)
|
(1)
|
(1)
|
(5)
|
(9)
|
(13)
|
(16)
|
(16)
|
(15)
|
(15)
|
(16)
|
(17)
|
(16)
|
(17)
|
(17)
|
(17)
|
(19)
|
(19)
|
(18)
|
(18)
|
(18)
|
(18)
|
(17)
|
(17)
|
(18)
|
(20)
|
(24)
|
(27)
|
(30)
|
(30)
|
(31)
|
(30)
|
(30)
|
(30)
|
(30)
|
(30)
|
(28)
|
(28)
|
(28)
|
(29)
|
(31)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
(7)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(39)
|
(297)
|
0
|
0
|
(257)
|
0
|
0
|
0
|
(278)
|
(223)
|
(227)
|
0
|
51
|
(62)
|
(60)
|
(60)
|
(62)
|
(6)
|
(4)
|
(4)
|
(2)
|
27
|
0
|
0
|
0
|
(251)
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
11
|
10
|
10
|
10
|
0
|
(0)
|
(0)
|
(1)
|
0
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
1
|
0
|
|
Pre-Tax Income |
29
N/A
|
35
+22%
|
38
+7%
|
43
+15%
|
28
-35%
|
19
-31%
|
11
-44%
|
16
+48%
|
19
+21%
|
14
-27%
|
(8)
N/A
|
(40)
-406%
|
(42)
-7%
|
(52)
-22%
|
(35)
+33%
|
(31)
+11%
|
(252)
-715%
|
(237)
+6%
|
(179)
+24%
|
(149)
+17%
|
20
N/A
|
(23)
N/A
|
(105)
-355%
|
(393)
-274%
|
(274)
+30%
|
(239)
+13%
|
(229)
+4%
|
43
N/A
|
(108)
N/A
|
(131)
-22%
|
(137)
-5%
|
(176)
-28%
|
(109)
+38%
|
(97)
+11%
|
(94)
+3%
|
(76)
+19%
|
(35)
+54%
|
(30)
+15%
|
(21)
+30%
|
(19)
+12%
|
(296)
-1 500%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(12)
|
(17)
|
(19)
|
(20)
|
(10)
|
(6)
|
(1)
|
(14)
|
(8)
|
(1)
|
2
|
16
|
7
|
(2)
|
(9)
|
(25)
|
42
|
37
|
34
|
15
|
(2)
|
3
|
11
|
49
|
1
|
8
|
7
|
6
|
8
|
4
|
5
|
10
|
5
|
2
|
(26)
|
(30)
|
(31)
|
(28)
|
0
|
3
|
43
|
|
Income from Continuing Operations |
17
|
18
|
19
|
24
|
18
|
14
|
10
|
2
|
11
|
14
|
(6)
|
(23)
|
(36)
|
(54)
|
(43)
|
(55)
|
(210)
|
(200)
|
(145)
|
(134)
|
19
|
(21)
|
(94)
|
(344)
|
(273)
|
(232)
|
(222)
|
49
|
(100)
|
(127)
|
(132)
|
(167)
|
(104)
|
(95)
|
(119)
|
(106)
|
(66)
|
(58)
|
(21)
|
(16)
|
(253)
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Net Income (Common) |
17
N/A
|
18
+11%
|
19
+4%
|
24
+24%
|
18
-25%
|
14
-21%
|
10
-27%
|
2
-79%
|
11
+429%
|
14
+23%
|
(6)
N/A
|
(22)
-291%
|
(35)
-55%
|
(53)
-53%
|
(43)
+19%
|
(55)
-29%
|
(223)
-303%
|
(213)
+5%
|
(158)
+26%
|
(147)
+7%
|
34
N/A
|
(6)
N/A
|
(79)
-1 293%
|
(329)
-314%
|
(273)
+17%
|
(232)
+15%
|
(222)
+4%
|
49
N/A
|
(100)
N/A
|
(127)
-27%
|
(132)
-4%
|
(167)
-26%
|
(104)
+38%
|
(95)
+9%
|
(119)
-25%
|
(106)
+11%
|
(66)
+38%
|
(58)
+12%
|
(21)
+64%
|
(16)
+24%
|
(253)
-1 480%
|
|
EPS (Diluted) |
41.24
N/A
|
45.75
+11%
|
47.75
+4%
|
58.99
+24%
|
44.24
-25%
|
34.74
-21%
|
25.49
-27%
|
5.25
-79%
|
27.74
+428%
|
34
+23%
|
-14.25
N/A
|
-55.75
-291%
|
-86.5
-55%
|
-132.5
-53%
|
-107.24
+19%
|
-138.5
-29%
|
-558.5
-303%
|
-531.74
+5%
|
-395.74
+26%
|
-367.5
+7%
|
84.25
N/A
|
-14.24
N/A
|
-198.5
-1 294%
|
-822.5
-314%
|
-682.5
+17%
|
-579.5
+15%
|
-554.24
+4%
|
35.07
N/A
|
-248.99
N/A
|
-253.2
-2%
|
-264.2
-4%
|
-277.5
-5%
|
-208
+25%
|
-135.85
+35%
|
-148.62
-9%
|
-88.08
+41%
|
-65.9
+25%
|
-48.58
+26%
|
-17.5
+64%
|
-13.33
+24%
|
-203.59
-1 427%
|